TMCnet

Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading ...

Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement ...
The Manila Times

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity ...

Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE (setmelanotide) for Patients with Acquired Hypothalamic Obesity

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...
Health.com

Signs and Symptoms of Bowel Obstruction To Watch For

Abdominal pain, bloating, and constipation are common symptoms of bowel obstruction. Partial bowel obstruction symptoms may come and go for days or weeks before worsening. Intussusception in children ...
Health.com

Understanding the Signs and Symptoms of Gout

Courtney Southwick is a writer focusing on health, nutrition, and disease. She has been blogging for the past two years at CourtneySouthwick.com. She writes blogs and articles for online publications ...